The company believed the product was performing well until August 2010 when it "received new information from the National Joint Registry of England and Wales reporting that 12% of ASR resurfacing patients and 13% of ASR Total Hip Replacement patients were undergoing second hip replacement surgery sooner than expected".

BBC: Andrew Robathan